Literature DB >> 12608704

Discussion of the role of the extracellular signal-regulated kinase-phospholipase A2 pathway in production of reactive oxygen species in Alzheimer's disease.

Jannike M Andersen1, Oddvar Myhre, Frode Fonnum.   

Abstract

In this paper we show that exposure of a rat brain synaptosome fraction to the amyloid beta peptide fragment betaA(25-35), but not the inverted peptide betaA(35-25), stimulated production of reactive oxygen species (ROS) in a concentration- and time-dependent manner. The ROS formation was attenuated by the tyrosine kinase inhibitor genistein, the mitogen-activated protein kinase inhibitor U0126, and the phospholipase A2 (PLA2) inhibitor 7,7-dimethyl-(5Z,8Z)-eicosadienoic acid. This strongly suggests that betaA(25-35) stimulated ROS production through an extracellular signal-regulated kinase-PLA2-dependent pathway. The interaction between these enzymes and their possible involvement in free radical formation in Alzheimer's disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608704     DOI: 10.1023/a:1022389503105

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  71 in total

1.  Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells.

Authors:  S Kao ; R K Jaiswal; W Kolch; G E Landreth
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

2.  A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7.

Authors:  J Y Channon; C C Leslie
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

3.  Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity.

Authors:  J V Bonventre; J H Gronich; R A Nemenoff
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

4.  Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

Authors:  D T Stephenson; C A Lemere; D J Selkoe; J A Clemens
Journal:  Neurobiol Dis       Date:  1996-02       Impact factor: 5.996

5.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

6.  The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters, dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes.

Authors:  E Mariussen; F Fonnum
Journal:  Toxicology       Date:  2001-02-21       Impact factor: 4.221

7.  The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation.

Authors:  H J Goldberg; M M Viegas; B L Margolis; J Schlessinger; K L Skorecki
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

8.  Arachidonic acid increases activation of NADPH oxidase in monocytic U937 cells by accelerated translocation of p47-phox and co-stimulation of protein kinase C.

Authors:  A Sellmayer; H Obermeier; U Danesch; M Aepfelbacher; P C Weber
Journal:  Cell Signal       Date:  1996-08       Impact factor: 4.315

9.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.

Authors:  T Arendt; M Holzer; A Grossmann; D Zedlick; M K Brückner
Journal:  Neuroscience       Date:  1995-09       Impact factor: 3.590

10.  Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain.

Authors:  R Campos-González; M S Kindy
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

View more
  12 in total

1.  Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.

Authors:  Michael D Jensen; Wenwen Sheng; Agnes Simonyi; Gary S Johnson; Albert Y Sun; Grace Y Sun
Journal:  Neurochem Int       Date:  2009-04-16       Impact factor: 3.921

Review 2.  Natural antioxidants for neurodegenerative diseases.

Authors:  Baolu Zhao
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Relative inhibitory potency of molinate and metabolites with aldehyde dehydrogenase 2: implications for the mechanism of enzyme inhibition.

Authors:  Erin M G Allen; David G R Anderson; Virginia R Florang; May Khanna; Thomas D Hurley; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2010-10-18       Impact factor: 3.739

Review 4.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

5.  Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.

Authors:  Antonella Bobba; Vito A Petragallo; Ersilia Marra; Anna Atlante
Journal:  Int J Alzheimers Dis       Date:  2010-09-02

Review 6.  Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease.

Authors:  Baolu Zhao
Journal:  Neurochem Res       Date:  2009-01-06       Impact factor: 3.996

7.  Methylmercury-induced changes in mitochondrial function in striatal synaptosomes are calcium-dependent and ROS-independent.

Authors:  Anne Dreiem; Richard F Seegal
Journal:  Neurotoxicology       Date:  2007-03-16       Impact factor: 4.294

8.  Genistein inhibits Aβ₂₅₋₃₅ -induced neurotoxicity in PC12 cells via PKC signaling pathway.

Authors:  Sijing Luo; Tian Lan; Weiliang Liao; Meishun Zhao; Hong Yang
Journal:  Neurochem Res       Date:  2012-09-05       Impact factor: 3.996

Review 9.  Study on the neuroprotective effects of Genistein on Alzheimer's disease.

Authors:  Xiaoying Duan; Yanshuang Li; Fei Xu; Hong Ding
Journal:  Brain Behav       Date:  2021-03-11       Impact factor: 2.708

Review 10.  The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).

Authors:  Jing Sun; Guangxian Nan
Journal:  Int J Mol Med       Date:  2017-04-21       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.